Fluoride Ion

Fluoride Ion

SCHEMBL584733

CC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[F-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.57
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.39
SNCA P37840 2/20 0.39
AOC3 Q16853 1/20 0.36
ESR1 P03372 1/20 0.36
TRPA1 O75762 1/20 0.35
MIF P14174 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GPR84 Q9NQS5 1/20 0.33
HKDC1 Q2TB90 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL28889553 1.00 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Fluoride Ion SCHEMBL22472149 0.97 HIF1A (0.55) HIF1ATSHRALDH1A1CYP1A2CYP2D6
SCHEMBL29563765 0.97 HIF1A (0.60) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Water SCHEMBL3419223 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL10592900 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL41863 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
SCHEMBL9513348 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL42887 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
SCHEMBL9513351 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL30173683 0.94 HIF1A (0.57) HIF1ATSHRALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304580-B2 Method for producing tris(perfluoroalkanesulfonyl)methide acid salt CENTRAL GLASS COMPANY, LIMITED (JP) 2012-11-06 US claimed
EP-2080753-B1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT CENTRAL GLASS CO LTD (JP) 2012-02-15 EP claimed
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt CENTRAL GLASS COMPANY, LIMITED (JP) 2010-01-28 US claimed
EP-2080753-A1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT Central Glass Company, Limited (JP) 2009-07-22 EP claimed
US-20240309240-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE FUJIMI INCORPORATED (JP) 2024-09-19 US disclosed
US-8304580-B2 Method for producing tris(perfluoroalkanesulfonyl)methide acid salt CENTRAL GLASS COMPANY, LIMITED (JP) 2012-11-06 US disclosed
EP-2080753-B1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT CENTRAL GLASS CO LTD (JP) 2012-02-15 EP disclosed
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt CENTRAL GLASS COMPANY, LIMITED (JP) 2010-01-28 US disclosed
EP-2080753-A1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT Central Glass Company, Limited (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt PFAS, AFF1, AFF2 HIF1A 3540/4885TSHR 58/4885ALDH1A1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.